Munoz, M. Aprepitant, When Used With Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients With Breast Cancer: Aprepitant in Breast Cancer Outcomes. PJHS-Lahore 2026, 7, 01-02.